Henry Brem's most recent trade in Galectin Therapeutics Inc was a trade of 60,000 Stock option (right to buy) done . Disclosure was reported to the exchange on March 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galectin Therapeutics Inc | Henry Brem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 60,000 | 60,000 | - | - | Stock option (right to buy) |